Skip to main content

Table 4 Meta-analytic pooled results of survival based on the ablation versus wedge resection

From: Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis

 

Number of studies

HR (95% CI)

Heterogeneity

Favor

Overall survival

3

1.63 (1.38, 1.93), P < 0.00001

I2 = 0%

SR

Progression-free survival

2

1.69 (1.31, 2.18), P < 0.00001

I2 = 0%

SR

Cancer-specific survival

2

1.72 (1.36, 2.18), P < 0.00001

I2 = 0%

SR

  1. HR hazard ratio, CI confidential interval, SR sublobar resection